-transparent.png){kind=logo}
A 55-year patient with obsessive-compulsive disorder showed clear improvement during 4 weeks of treatment with intranasal oxytocin compared to 4 weeks of intranasal placebo. This improvement was concurrent with the development of severe memory disturbances, supporting the amnestic properties of the peptide. However, the patient also developed psychotic symptoms and a marked decrease in plasma sodium and osmolality, which may have masked the obsessive symptomatology. This case highlights the need for careful monitoring in long-term oxytocin therapy.
Related Publications
M Ansseau, and
J J Legros, and
C Mormont, and
J L Cerfontaine, and
P Papart, and
V Geenen, and
F Adam, and
G Franck
September 1996,
Biological psychiatry,
M Ansseau, and
J J Legros, and
C Mormont, and
J L Cerfontaine, and
P Papart, and
V Geenen, and
F Adam, and
G Franck
January 1992,
Peptides,
M Ansseau, and
J J Legros, and
C Mormont, and
J L Cerfontaine, and
P Papart, and
V Geenen, and
F Adam, and
G Franck
May 1992,
The American journal of psychiatry,
M Ansseau, and
J J Legros, and
C Mormont, and
J L Cerfontaine, and
P Papart, and
V Geenen, and
F Adam, and
G Franck
April 2017,
The Journal of clinical psychiatry,
M Ansseau, and
J J Legros, and
C Mormont, and
J L Cerfontaine, and
P Papart, and
V Geenen, and
F Adam, and
G Franck
January 2015,
Neuropsychobiology,
M Ansseau, and
J J Legros, and
C Mormont, and
J L Cerfontaine, and
P Papart, and
V Geenen, and
F Adam, and
G Franck
January 1997,
Comprehensive psychiatry,
M Ansseau, and
J J Legros, and
C Mormont, and
J L Cerfontaine, and
P Papart, and
V Geenen, and
F Adam, and
G Franck
January 1992,
New directions for mental health services,
M Ansseau, and
J J Legros, and
C Mormont, and
J L Cerfontaine, and
P Papart, and
V Geenen, and
F Adam, and
G Franck
July 1992,
Hospital & community psychiatry,
M Ansseau, and
J J Legros, and
C Mormont, and
J L Cerfontaine, and
P Papart, and
V Geenen, and
F Adam, and
G Franck
January 2008,
The Israel journal of psychiatry and related sciences,
M Ansseau, and
J J Legros, and
C Mormont, and
J L Cerfontaine, and
P Papart, and
V Geenen, and
F Adam, and
G Franck
April 2014,
BMJ (Clinical research ed.),
